ERNA-101 remains on track for IND-enabling studies in 2025, with first-in-human studies targeted for 2026.

Feeling Low? Your Ultra-Processed Food Habit Might Be to BlameA recent study published in Food Science & Nutrition has highlighted a strong ...

In a recent clip, Dr Jackson-Spence shared a number of different symptoms that could actually be something more serious - ...

Every year, we’re reminded of the importance of awareness, early detection, and action in the face of one of the most ...

The addition of bevacizumab to first-line (1L) chemotherapy offers real-world benefit to patients with epithelial ovarian cancer with high-risk prognostic factors.

A cancer survivor is raising awareness about the importance of genetic testing. Why she believes it can be imperative to ...

A Ludwig Cancer Research study has identified a key mechanism by which advanced ovarian cancers suppress anti-tumor immune responses and resist immunotherapies.

The early months of 2025 have seen a surge of research centered on cannabidiol (CBD), with studies investigating its role in ...

In line with previous clinical trial findings, real-world data show that bevacizumab improves outcomes in patients with ...

For ovarian cysts that cause pain, medications such as acetaminophen, ibuprofen, or another non-steroidal anti-inflammatory ...

Clinical update on LORIKEET, a randomized 150-patient Phase 2 study of lorigerlimab in combination with docetaxel in patients ...

She had made repeated visits to the GP with symptoms, which over the following years became persistent and gradually worse.